About: idiopathic pulmonary arterial hypertension

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: idiopathic pulmonary arterial hypertension Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
description	синдром або хвороба (uk)
exact match	wds:Q5832696-96D39CB9-2A4C-4946-8FD9-3675A94B0D16
exact match	http://www.orpha.net/ORDO/Orphanet_275766
Mondo ID	wds:Q5832696-0CCB6869-A8F4-460C-97C9-14AA116A9F06
DiseasesDB	wds:Q5832696-21065437-4805-4F8F-AF34-FD08C3A93381
Mondo ID	http://purl.obolibrary.org/obo/MONDO_0017147
Mondo ID	MONDO_0017147
DiseasesDB	10998
rdfs:label	hipertensión arterial pulmonar idiopática (es) idiopathic pulmonary arterial hypertension (en) maladie d'Ayerza (fr) синдром Аєрзи (uk) 特发性肺动脉高压 (zh)
skos:prefLabel	hipertensión arterial pulmonar idiopática (es) idiopathic pulmonary arterial hypertension (en) maladie d'Ayerza (fr) синдром Аєрзи (uk) 特发性肺动脉高压 (zh)
name	hipertensión arterial pulmonar idiopática (es) idiopathic pulmonary arterial hypertension (en) maladie d'Ayerza (fr) синдром Аєрзи (uk) 特发性肺动脉高压 (zh)
image	wds:Q5832696-F58774B5-9964-4646-A5CD-2A3222FFC9B6
instance of	wds:Q5832696-11395A0B-AA0D-451B-8DE6-9392F1E4E032
discoverer or inventor	wds:Q5832696-bcc914f8-4608-5b65-597e-a653f6686de2
image
instance of	class of disease
discoverer or inventor	Abel Ayerza
subclass of	wds:Q5832696-7D18C2EE-DC98-43CE-B4DD-682860A347A6 wds:Q5832696-b039833a-4e0f-f461-cbc2-72cbd6cf90ba wds:Q5832696-c015d74e-4694-f5c2-b025-578c75ddfc03
subclass of	syndrome pulmonary hypertension primary pulmonary hypertension
eMedicine ID	wds:Q5832696-2549277f-41f4-5f32-ab4f-23b25752d13d
eMedicine ID	301450
Orphanet ID	wds:Q5832696-5B991060-6404-41FC-BBA4-7AA0E57F72D6
ICD-9-CM	wds:Q5832696-FAC7E276-88B0-4DEB-911B-30C8383F2829
ICD-10-CM	wds:Q5832696-2298A7DF-3BDE-4185-A61F-26D3AA175CBC
PatientsLikeMe condition ID	wds:Q5832696-25ae096f-4e40-88d7-8487-30eda37820ab
Orphanet ID	275766
ICD-9-CM	416.0
ICD-10-CM	I27.0
PatientsLikeMe condition ID	ipah-idiopathic-pulmonary-arterial-hypertension
skos:altLabel	Ayerza's disease (en) Ayerza's syndrome (en) IPAH (en) Primary pulmonary arterial hypertension (en) enfermedad de Ayerza (es) hypertension artérielle pulmonaire idiopathique (fr) síndrome de Ayerza (es) Аєрзи синдром (uk) Аєрзи хвороба (uk) хвороба Аєрзи (uk)
UMLS CUI	wds:Q5832696-7715a36f-4f33-6b4f-f0b2-b2000fdc4740 wds:Q5832696-A41A5C83-E84E-4D69-83DD-37E51B38EFCE wds:Q5832696-E2041D5E-FE9B-4D11-A2A9-817109DA131B
MedlinePlus ID	wds:Q5832696-95441A56-63C0-480A-8F77-630FB007E4E3
UMLS CUI	C0004468 C0152171 C3203102
MedlinePlus ID	000378
is owl:sameAs of	idiopathic pulmonary arterial hypertension
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q5832696 https://es.wikipedia.org/wiki/Hipertensi%C3%B3n_arterial_pulmonar_idiop%C3%A1tica https://uk.wikipedia.org/wiki/%D0%A1%D0%B8%D0%BD%D0%B4%D1%80%D0%BE%D0%BC_%D0%90%D1%94%D1%80%D0%B7%D0%B8
is main subject of	Is methamphetamine use associated with idiopathic pulmonary arterial hypertension? Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertension. Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension Clinical and prognostic relevance of echocardiographic evaluation of right ventricular geometry in patients with idiopathic pulmonary arterial hypertension. Left Ventricular Dysfunction Induced by Nonsevere Idiopathic Pulmonary Arterial Hypertension Continuous intravenous iloprost to revert treatment failure of first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension. The impact of pulmonary arterial hypertension-targeted therapy on survival in Chinese patients with idiopathic pulmonary arterial hypertension Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension Effects of adrenomedullin inhalation on hemodynamics and exercise capacity in patients with idiopathic pulmonary arterial hypertension. Warfarin in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. A Bayesian approach to evaluating treatment for uncommon disease Effect of warfarin anticoagulation on thrombin generation in patients with idiopathic pulmonary arterial hypertension. New predictors of outcome in idiopathic pulmonary arterial hypertension Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension. Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension Long-term outcome of bosentan treatment in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with the scleroderma spectrum of diseases Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension. Nitrosation-dependent caveolin 1 phosphorylation, ubiquitination, and degradation and its association with idiopathic pulmonary arterial hypertension Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial Missense mutations of the BMPR1B (ALK6) gene in childhood idiopathic pulmonary arterial hypertension Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension Role of Endothelium-derived CC Chemokine Ligand 2 in Idiopathic Pulmonary Arterial Hypertension Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension Shorter survival in familial versus idiopathic pulmonary arterial hypertension is associated with hemodynamic markers of impaired right ventricular function Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software